| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/02/2011 | EP1248613B1 Clonidine preparations |
| 03/02/2011 | EP1064942B9 Sustained release preparation of a macrolide |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/02/2011 | CN1939916B Compound for treating AIDS |
| 03/02/2011 | CN1918158B Compounds and compositions as protein kinase inhibitors |
| 03/02/2011 | CN1674935B Biofunctional composition containing CpG or oligo-/polynucleotide and toxin or enterotoxin |
| 03/02/2011 | CN101983203A Beta-lactamase inhibitors |
| 03/02/2011 | CN101983199A 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
| 03/02/2011 | CN101983198A Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 03/02/2011 | CN101983195A Novel polymorphs and processes for their preparation |
| 03/02/2011 | CN101983193A Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder |
| 03/02/2011 | CN101983191A Oxim derivatives as hsp90 inhibitors |
| 03/02/2011 | CN101983188A Indolinone compound |
| 03/02/2011 | CN101983072A Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 03/02/2011 | CN101983064A Absorbent ingestible agents and associated methods of manufacture and use |
| 03/02/2011 | CN101983063A Anti-infective agents and uses thereof |
| 03/02/2011 | CN101983062A Abca-1 elevating compounds and the use thereof |
| 03/02/2011 | CN101983061A Certain chemical entities, compositions and methods |
| 03/02/2011 | CN101983060A Methods and compositions for treating respiratory disease |
| 03/02/2011 | CN101983059A New 2,3,4,5-terahydro-1h-pyrido[ 4,3-b] indole compounds and methods of use thereof |
| 03/02/2011 | CN101983058A Compositions and methods for alleviating depression or improving cognition |
| 03/02/2011 | CN101983057A Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds |
| 03/02/2011 | CN101983056A Preventive and/or remedy for vascular diseases |
| 03/02/2011 | CN101983055A Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 03/02/2011 | CN101983054A Orally rapidly disintegrating tablet comprising imidafenacin |
| 03/02/2011 | CN101983053A Anti-peptic ulcer composition comprising rice prolamin |
| 03/02/2011 | CN101983052A Galenic form for the oral transmucosal delivery of triptans |
| 03/02/2011 | CN101983051A Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
| 03/02/2011 | CN101982468A Novel oxazolidinone derivatives and pharmaceutical compositions comprising the derivatives |
| 03/02/2011 | CN101982467A Lignans compounds contained in Schisandra chinensis, and preparation method and application thereof |
| 03/02/2011 | CN101982465A Flavonoid compound extracted from liquorice and preparation method and application thereof |
| 03/02/2011 | CN101982464A Annonaceous acetogenin compound and synthesis method and application thereof |
| 03/02/2011 | CN101982462A Compound separated and extracted by marine fusarium and application thereof |
| 03/02/2011 | CN101982199A Compositions containing acid-unstable physiologically active compounds and process for producing the same |
| 03/02/2011 | CN101982198A Perfusion medicinal oil for treating hysteritis of cow and preparation method thereof |
| 03/02/2011 | CN101982190A External cream for treating wind cold by utilizing percutaneous absorption technology |
| 03/02/2011 | CN101982182A Medicine for treating burn and scald and preparation method thereof |
| 03/02/2011 | CN101982179A Xiao er Anfen Huang Namin granule and preparation method thereof |
| 03/02/2011 | CN101982176A Compound sodium selenite-vitamin E oral nano-emulsion preparation for livestock and preparation method thereof |
| 03/02/2011 | CN101982175A Application of pedunculoside in preparing medicine for treating cerebral ischemia |
| 03/02/2011 | CN101982174A Formula of compound medicine preparation for relieving cough and preventing asthma and preparation method thereof |
| 03/02/2011 | CN101982173A Danofloxacin mesylate-amoxicillinsuspension injection applicable to livestock and poultry as well as preparation and application thereof |
| 03/02/2011 | CN101982172A Combined drug of Ginkgolide and Ginkgo flavone as well as preparation and application thereof |
| 03/02/2011 | CN101982171A Application of fenugreek biflavone glycosides for preparing anti-virus or/and anti-tumor drugs |
| 03/02/2011 | CN101982170A Amide compound and application thereof in preparing monoamine oxidase inhibitor |
| 03/02/2011 | CN101982168A Quercetin nano-micelle preparation and preparation method thereof |
| 03/02/2011 | CN101982167A Butoconazole nitrate suppository used in gynaecology, preparation method and application thereof |
| 03/02/2011 | CN101982166A Slow release formulation of moxifloxacin and preparation method thereof |
| 03/02/2011 | CN101543488B A medicine containing caffeic acid 3,4-dihydroxyl phenethyl ester and its uses |
| 03/02/2011 | CN101538272B Phenyl propanoid derivative, preparation method thereof and application thereof to preparation of medicines resisting breast cancer |
| 03/02/2011 | CN101322709B Medicament composition containing aripiprazole and preparation thereof |
| 03/02/2011 | CN101305011B Pyridine derivatives and their use in the treatment of psychotic disorders |
| 03/02/2011 | CN101278907B Coenzyme Q10 injection |
| 03/02/2011 | CN101199449B Application of hyamine antibiont on dentistry antibacterial replacement material |
| 03/02/2011 | CN101193869B Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/02/2011 | CN101193656B Novel triglyceride reducing agent |
| 03/02/2011 | CN101185649B Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 03/02/2011 | CN101171235B Dipyrazoles as central nervous system agents |
| 03/02/2011 | CN101104604B Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
| 03/02/2011 | CN101099758B Compound gingko leaves preparation and its preparing process |
| 03/02/2011 | CN101085756B Endothelin antagonist |
| 03/02/2011 | CN101084889B Ginkgolide freezing-dried powder injection and preparation method thereof |
| 03/02/2011 | CN101084225B Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity |
| 03/02/2011 | CN101035760B Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 03/02/2011 | CN101020637B Preparation process and application of resemary acid |
| 03/02/2011 | CA2774199A1 Improved purification of multi-specific receptors |
| 03/02/2011 | CA2714374A1 Weight loss composition and method |
| 03/01/2011 | USRE42191 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 03/01/2011 | US7899527 Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase |
| 03/01/2011 | US7897815 Hexafluoroisopropanol derivatives |
| 03/01/2011 | US7897791 Purifications of pomegranate ellagitannins and their uses thereof |
| 03/01/2011 | US7897789 Vitamin D receptor modulators |
| 03/01/2011 | US7897788 Indol-1-yl-acetic acid derivatives |
| 03/01/2011 | US7897771 Fused heterocyclic compounds |
| 03/01/2011 | US7897766 [3H]-(S,S)-2,2-dimethyl-5-(6-phenyl-pyridazin-3-yl)-5-aza-2-azonia-bicyclo[2.2.1]heptane, iodide; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, mild cognitive impairment, age-associated memory impairment |
| 03/01/2011 | US7897765 Therapeutic compounds and uses thereof |
| 03/01/2011 | US7897763 Process for the preparation of substituted phenylalanines |
| 03/01/2011 | US7897762 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897740 Secreted protein called 36P6D5 characteristic of tumors |
| 03/01/2011 | US7897733 Rapamycin conjugates and antibodies |
| 03/01/2011 | US7897646 Use for budesonide and formoterol |
| 03/01/2011 | US7897645 Herpesvirus-derived therapeutic agent for pain |
| 03/01/2011 | US7897644 Antiinflammatory agents; analgesics |
| 03/01/2011 | US7897643 Biphenyl carboxylic acids and derivatives thereof |
| 03/01/2011 | US7897642 Compositions and methods for dry eye syndrome |
| 03/01/2011 | US7897641 Propionyl L-carnitine and glycine, serine, alanine or arginine |
| 03/01/2011 | US7897640 Bactericide, viricide, antitumor agents; anticancer agents |
| 03/01/2011 | US7897639 Amine group that, upon hydrolysis, becomes a component of a pharmacologically active agent for treatment of nervous system disordres |
| 03/01/2011 | US7897638 Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules |
| 03/01/2011 | US7897637 Methods of using flavonoids to enhance memory |
| 03/01/2011 | US7897636 Sulfamide derivative useful for the treatment of epilepsy |
| 03/01/2011 | US7897635 HIV protease inhibitors |
| 03/01/2011 | US7897634 Pyrazoles for the treatment of obesity and other CNS disorders |
| 03/01/2011 | US7897633 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 03/01/2011 | US7897632 Multi-cyclic cinnamide derivatives |
| 03/01/2011 | US7897631 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives |
| 03/01/2011 | US7897630 5-aryl isoxazolines for controlling invertebrate pests |
| 03/01/2011 | US7897629 Therapeutic compounds |
| 03/01/2011 | US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |